Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Brainsway Ltd. Sponsored ADR (BWAY : NSDQ)
 
 • Company Description   
BrainsWay Ltd. is a commercial stage medical device company. It is focused on the development and sale of non-invasive neuromodulation products using the Company's proprietary Deep Transcranial Magnetic Stimulation technology for the treatment of major depressive disorder and obsessive-compulsive disorder. BrainsWay Ltd. is based in Jerusalem, Israel.

Number of Employees: 120

 
 • Price / Volume Information   
Yesterday's Closing Price: $12.87 Daily Weekly Monthly
20 Day Moving Average: 48,818 shares
Shares Outstanding: 18.90 (millions)
Market Capitalization: $243.18 (millions)
Beta: 1.40
52 Week High: $13.66
52 Week Low: $5.98
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week 12.30% 8.94%
12 Week 54.13% 33.61%
Year To Date 36.48% 28.94%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
16 HARTUM STREET RAD TOWER 14TH FLOOR HAR HAHOTZVIM
-
JERUSALEM,L3 9777516
ISR
ph: 972-2582-4030
fax: -
ir@brainsway.com http://www.brainsway.com
 
 • General Corporate Information   
Officers
Hadar Levy - Chief Executive Officer
Ami Boehm - Chairman of the Board
Ido Marom - Chief Financial Officer
Avner Hagai - Director
Eti Mitrany - Director

Peer Information
Brainsway Ltd. Sponsored ADR (BJCT)
Brainsway Ltd. Sponsored ADR (CADMQ)
Brainsway Ltd. Sponsored ADR (APNO)
Brainsway Ltd. Sponsored ADR (UPDC)
Brainsway Ltd. Sponsored ADR (IMTIQ)
Brainsway Ltd. Sponsored ADR (CYGN)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED PRODUCTS
Sector: Medical
CUSIP: 10501L106
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/05/25
Share - Related Items
Shares Outstanding: 18.90
Most Recent Split Date: (:1)
Beta: 1.40
Market Capitalization: $243.18 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $0.07 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $0.31 Payout Ratio: 0.00
Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/05/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: 42.20
Trailing 12 Months: 64.35
PEG Ratio: -
Price Ratios
Price/Book: 3.81
Price/Cash Flow: 51.61
Price / Sales: 5.60
EPS Growth
vs. Year Ago Period: 300.00%
vs. Previous Quarter: -50.00%
Sales Growth
vs. Year Ago Period: 26.84%
vs. Previous Quarter: 1.07%
ROE
06/30/25 - -
03/31/25 - 7.35
12/31/24 - 6.11
ROA
06/30/25 - -
03/31/25 - 4.72
12/31/24 - 3.93
Current Ratio
06/30/25 - -
03/31/25 - 5.03
12/31/24 - 5.19
Quick Ratio
06/30/25 - -
03/31/25 - 4.75
12/31/24 - 4.90
Operating Margin
06/30/25 - -
03/31/25 - 9.01
12/31/24 - 7.12
Net Margin
06/30/25 - -
03/31/25 - 9.01
12/31/24 - 7.12
Pre-Tax Margin
06/30/25 - -
03/31/25 - 10.22
12/31/24 - 8.43
Book Value
06/30/25 - -
03/31/25 - 3.38
12/31/24 - 3.31
Inventory Turnover
06/30/25 - -
03/31/25 - 2.68
12/31/24 - 2.66
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©